A Clinical Case Study in Comprehensive Fertility Optimization

A 34-year-old female and 36-year-old male partner presented after three failed IVF cycles with a diagnosis of “unexplained infertility.” Comprehensive evaluation revealed subclinical hypothyroidism (TSH 3.8 mIU/L), severe Vitamin D deficiency (22 ng/mL), depleted ferritin (28 ng/mL), male sperm DNA fragmentation of 38%, and a previously undetected Ureaplasma urealyticum infection in both partners. A 90-day preconception protocol targeting each identified cause resulted in natural conception in the fourth cycle post-intervention, with a sustained pregnancy carried to term. This case illustrates how the “unexplained” label obscures multiple identifiable and addressable root causes that, when systematically corrected, may restore fertility without assisted reproductive technology.

Key Clinical Takeaways

• Three failed IVF cycles did not identify the actual barriers to conception — the standard workup missed thyroid dysfunction, nutrient deficiencies, male DNA fragmentation, and a bilateral Ureaplasma infection, all of which directly impair fertility
• TSH of 3.8 mIU/L was reported as “normal” despite carrying 2-3x miscarriage risk — the standard reference range (0.4-4.5) failed this patient; optimization to 1.0-2.0 mIU/L is essential for preconception and early pregnancy
• Sperm DNA fragmentation of 38% was never assessed despite normal standard semen analysis — this single overlooked test revealed the male factor contribution that ICSI bypassed without addressing
• Ureaplasma infection in both partners was producing subclinical reproductive damage — the organism increases sperm DNA fragmentation, triggers endometrial immune activation, and impairs implantation, yet is not part of standard fertility screening
• A 90-day preconception protocol addressing all identified root causes preceded natural conception — the 72-90 day sperm development cycle and the ovarian folliculogenesis timeline both support a 3-month optimization window before conception attempts

Presentation: The Failed IVF Patient

Patient A, a 34-year-old nulligravida, and Patient B, her 36-year-old male partner, were referred for evaluation after three unsuccessful IVF-ICSI cycles at an outside clinic. Their reproductive history was a study in frustration: every laboratory, every procedure, every transfer had been performed correctly according to conventional protocol, and every cycle had failed.

Initial Clinical History

The couple had been attempting conception for 28 months before initiating IVF. Their initial fertility evaluation at the referring clinic included:

• Day 3 labs: FSH 6.2 mIU/mL, LH 4.8 mIU/mL, estradiol 42 pg/mL, AMH 2.8 ng/mL
• TSH: 3.8 mIU/L (reported as “normal”)
• Hysterosalpingography: Bilateral tubal patency confirmed
• Semen analysis (Patient B): Volume 3.2 mL, count 48 million/mL, motility 42%, morphology 6% (WHO criteria)
• Progesterone (Day 21): 9.2 ng/mL (reported as “borderline low”)

Based on these results, the couple received the diagnosis of “unexplained infertility” and was directed to IVF.

IVF Cycle Summaries

Cycle 1: Standard antagonist protocol. 8 oocytes retrieved, 6 mature, 4 fertilized via ICSI. Two embryos transferred on Day 3 (6-cell, grade B). Negative beta-hCG at 14 days.

Cycle 2: Modified protocol with increased gonadotropin dosage. 10 oocytes retrieved, 7 mature, 5 fertilized. Single blastocyst transfer (4BB). Positive beta-hCG at 8.2 mIU/mL, then decline — biochemical pregnancy.

Cycle 3: Same protocol. 9 oocytes, 6 mature, 4 fertilized. Two blastocysts transferred (3BC and 4CB). Negative beta-hCG.

After the third failure, the couple was advised to consider donor eggs or additional cycles with adjusted protocols. They sought a second opinion.

Comprehensive Evaluation: What the Standard Workup Missed

The initial evaluation that produced the “unexplained” diagnosis was not incorrect within its scope — it was simply incomplete. Each result that had been reported as “normal” was reconsidered against functional, reproductive-specific thresholds rather than population-based reference ranges.

Thyroid: Normal by Lab Standards, Abnormal for Fertility

Patient A’s TSH of 3.8 mIU/L fell within the laboratory reference range of 0.4-4.5 mIU/L. No further thyroid assessment had been performed.

Expanded thyroid evaluation revealed:

The picture was clear: subclinical autoimmune hypothyroidism with impaired T4-to-T3 conversion. The elevated TPO antibodies independently increased miscarriage risk regardless of the TSH value. The TSH of 3.8 mIU/L — “normal” on the report — carried a 2-3x elevated miscarriage risk and was associated with reduced conception probability.

The prior clinic had not ordered Free T3, Free T4, or thyroid antibodies. The TSH was “in range,” and the investigation was closed.

Nutrient Deficiencies: The Invisible Substrate

Nutritional assessment — entirely absent from the prior evaluation — revealed multiple deficiencies directly impairing reproductive function:

The Vitamin D level of 22 ng/mL placed Patient A in the deficient range, associated with a 40% reduced chance of conception per cycle. The ferritin of 28 ng/mL — while above the laboratory threshold for iron deficiency (12 ng/mL) — was well below the 50 ng/mL level required for optimal ovulatory function. The B12 of 284 pg/mL fell below the 300 pg/mL threshold associated with increased miscarriage risk.

Each of these deficiencies independently impairs fertility. In combination, they create a nutrient environment fundamentally incompatible with optimal reproductive function — yet none had been assessed.

Male Factor: The Semen Analysis Illusion

Patient B’s semen analysis had been reported as “normal” at the referring clinic. The count of 48 million/mL exceeded the WHO lower reference limit of 15 million/mL. The motility of 42% approached the 40% threshold. The morphology of 6% (WHO criteria) was technically above the 4% cutoff.

However, the semen analysis tells only part of the story. Additional male factor assessment revealed:

The DNA fragmentation of 38% — never previously assessed — indicated that more than a third of Patient B’s sperm carried damaged DNA. This finding alone may explain the cycle outcomes: ICSI selects a single sperm and injects it, but if that sperm carries fragmented DNA, the resulting embryo may fertilize and begin development, then arrest during implantation or early gestation.

The elevated estradiol relative to testosterone suggested a mild estrogen-testosterone imbalance, potentially related to body composition, environmental estrogen exposure, or subclinical metabolic factors.

Hidden Infection: The Undetected Pathogen

PCR testing for atypical genital pathogens — not performed at the referring clinic — revealed:

• Ureaplasma urealyticum: Positive in both partners
• Mycoplasma hominis: Negative
• Chlamydia trachomatis: Negative (prior antibody testing also negative)

Ureaplasma colonization is common and its pathogenicity debated, but in the context of infertility and elevated sperm DNA fragmentation, its clinical significance becomes apparent. Ureaplasma increases reactive oxygen species in semen, directly contributing to DNA fragmentation. It also triggers subclinical endometrial inflammation that may impair implantation.

The infection had likely been present for months or years, silently contributing to both partners’ reproductive impairment. It was not detected because it was never tested.

The 90-Day Preconception Protocol

Based on the comprehensive findings, a 90-day preconception protocol was designed for both partners. The 90-day window was selected deliberately to align with the spermatogenic cycle (approximately 72-90 days from spermatogonia to mature spermatozoa) and to allow sufficient time for thyroid optimization, nutrient repletion, and infection resolution.

Patient A: Female Protocol

Thyroid Optimization

• Levothyroxine 50 mcg daily, with dose titration targeting TSH 1.0-2.0 mIU/L
• Selenium 200 mcg daily to support T4-to-T3 conversion and reduce thyroid antibody titers
• TSH rechecked at 6 weeks: 2.1 mIU/L; dose adjusted to 75 mcg
• TSH at 12 weeks: 1.6 mIU/L; Free T4 1.2 ng/dL; Free T3 3.4 pg/mL

Nutrient Repletion

• Vitamin D3 5,000 IU daily with K2 100 mcg, recheck at 8 weeks: 44 ng/mL; dose reduced to 4,000 IU; level at 12 weeks: 52 ng/mL
• Iron bisglycinate 25 mg daily with Vitamin C; ferritin recheck at 12 weeks: 54 ng/mL
• Methylcobalamin 2,000 mcg sublingual daily; B12 at 12 weeks: 528 pg/mL
• Methylfolate (5-MTHF) 800 mcg daily; folate at 12 weeks: 14.6 ng/mL
• Magnesium glycinate 400 mg nightly

Infection Treatment

• Doxycycline 100 mg twice daily for 14 days (both partners treated simultaneously)
• Retest PCR at 6 weeks post-treatment: negative both partners

Cycle Monitoring

• Basal body temperature tracking initiated
• Day 21 progesterone assessed at first natural cycle post-treatment: 12.8 ng/mL (improved from 9.2)

Patient B: Male Protocol

DNA Fragmentation Reduction

• L-Carnitine 1,500 mg twice daily
• Acetyl-L-Carnitine 500 mg twice daily
• CoQ10 (ubiquinol) 200 mg twice daily
• Vitamin C 1,000 mg daily
• Vitamin E 400 IU daily
• Zinc 30 mg daily with copper 2 mg

Hormone Optimization

• Eliminated all plastic food containers and water bottles (BPA/phthalate reduction)
• Switched to organic produce for highest-pesticide items (EWG Dirty Dozen)
• Resistance training 3x weekly (natural testosterone optimization)
• Eliminated laptop use on lap and hot tub exposure

Infection Treatment

• Doxycycline 100 mg twice daily for 14 days (concurrent with partner)

Lifestyle Modifications

• Sleep optimization: 7.5-8 hours nightly, no screens 1 hour before bed
• Alcohol eliminated; caffeine reduced to <200 mg daily
• Loose underwear; no restrictive clothing

Outcomes: The 90-Day Transformation

Laboratory Changes at 90 Days

Patient A — Female

Patient B — Male

Conception and Pregnancy

The couple was advised to attempt natural conception beginning after the 90-day protocol completion. At the fourth cycle post-intervention (approximately 16 weeks after initiating the protocol), Patient A reported a positive home pregnancy test.

• Beta-hCG at 14 days post-ovulation: 286 mIU/mL (appropriate doubling)
• Progesterone at 6 weeks: 18.2 ng/mL (adequate, supported with continuation of levothyroxine and prenatal supplementation)
• TSH in early pregnancy: 1.8 mIU/L (maintained within optimal range)
• First ultrasound at 7 weeks: Single intrauterine pregnancy with cardiac activity, appropriate growth
• Nuchal translucency at 12 weeks: Normal
• Anatomy scan at 20 weeks: Normal, no anomalies

The pregnancy was carried to term without complication. A healthy infant was delivered at 39+2 weeks, 7 lbs 4 oz, APGAR scores 8 and 9.

Clinical Analysis: Why IVF Failed and Root-Cause Correction Succeeded

The three failed IVF cycles did not fail because IVF technology is inadequate. They failed because the technology was applied without addressing the underlying conditions that sabotaged reproductive function at every stage.

The thyroid dysfunction impaired follicular development, endometrial receptivity, and progesterone production. IVF superovulation created multiple follicles, but the thyroid-impaired endometrial environment could not support implantation. The biochemical pregnancy in Cycle 2 — the closest to success — is consistent with marginal implantation in a suboptimal endometrial environment, followed by early loss.

The nutrient deficiencies compromised oocyte quality, hormone synthesis, and immune function at the maternal-fetal interface. Vitamin D deficiency alone reduces IVF success rates; combined with depleted ferritin and suboptimal B12, the nutritional substrate for conception was fundamentally insufficient.

The elevated DNA fragmentation meant that even with ICSI — which selects a single sperm for injection — the probability of selecting a sperm with intact DNA was reduced. With 38% fragmentation, nearly 4 in 10 sperm carried damaged genetic material. ICSI bypassed the motility and morphology issues but could not bypass the DNA integrity problem.

The Ureaplasma infection created chronic low-grade inflammation in both the endometrium and the male reproductive tract, increasing oxidative stress and immune activation that impaired implantation and sperm quality simultaneously.

IVF was technically proficient but biologically inappropriate — it attempted to overcome obstacles that should have been removed rather than bypassed. When those obstacles were systematically identified and addressed, natural conception occurred without assisted technology.

Implications for Clinical Practice

This case is not unique. The pattern — incomplete evaluation, “unexplained” diagnosis, IVF recommendation, cycle failure — repeats across fertility clinics daily. The specific causes vary (the next couple may have antiphospholipid antibodies, or a hidden varicocele, or heavy metal burden), but the structural failure is consistent: the standard evaluation is too narrow to identify the causes it labels “unexplained.”

A comprehensive fertility evaluation before initiating IVF may identify addressable root causes in 70-85% of couples labeled “unexplained.” For a significant proportion of these couples, addressing those causes may enable natural conception or substantially improve IVF outcomes when assisted reproduction remains necessary.

The 90-day preconception protocol is not an alternative to IVF — it is a prerequisite. Whether conception occurs naturally or with assistance, the optimization of thyroid function, nutrient status, male factor integrity, infection clearance, and toxin reduction creates the biological conditions under which conception is most likely to succeed and pregnancy is most likely to be sustained.

References

1. Maraka S, et al. Thyroid Hormone Therapy for Subclinical Hypothyroidism and Infertility: A Systematic Review. Thyroid. 2018;28(6):739-745. doi:10.1089/thy.2017.0645
2. Agarwal A, et al. Sperm DNA Fragmentation: A Critical Assessment of Clinical Significance. Andrologia. 2023;55(S1):e14350. doi:10.1111/and.14350
3. Chu J, et al. Antioxidant Supplementation for Male Subfertility: A Cochrane Review. Cochrane Database Syst Rev. 2023;4:CD007411. doi:10.1002/14651858.CD007411.pub3
4. Paffoni A, et al. Vitamin D Status and Outcome of Assisted Reproductive Technology: A Prospective Cohort Study. Hum Reprod. 2018;33(2):252-260. doi:10.1093/humrep/dex357
5. Zini A, et al. Ureaplasma urealyticum Infection and Male Infertility: A Systematic Review and Meta-Analysis. Andrology. 2021;9(4):1104-1112. doi:10.1111/andr.13005

Medical Disclaimer

This article is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Always consult with a qualified healthcare provider before initiating, modifying, or discontinuing any medical intervention. The information presented reflects current evidence and clinical observations but should not replace individualized medical care.

For structured protocols and implementation guidance, visit Human Optimization Lab.